SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divi's Laboratories zooms on inking pact with global pharma company

26 May 2025 Evaluate

Divi's Laboratories is currently trading at Rs 6744.00, up by 263.30 points or 4.06% from its previous closing of Rs 6480.70 on the BSE.

The scrip opened at Rs 6642.80 and has touched a high and low of Rs 6764.00 and Rs 6610.00 respectively. So far 39525 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52-week high of Rs 6,764.00 on 26-May-2025 and a 52-week low of Rs 4100.70 on 24-May-2024.

Last one week high and low of the scrip stood at Rs 6764.75 and Rs 6358.30 respectively. The current market cap of the company is Rs 179032.01 crore.

The promoters holding in the company stood at 51.89%, while Institutions and Non-Institutions held 38.72% and 9.39% respectively.

Divi's Laboratories has signed long term manufacturing and supply agreement with a global pharma company. Under this agreement, the company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties. The cost of capacity addition for manufacturing under this agreement is estimated to be Rs 650 to Rs 750 crore, which will be funded from the capacity reservation advance proposed to be paid by the customer phase wise under this Agreement.

Divi's Laboratories is one of the leading pharmaceutical companies in the world.

Divis Lab Share Price

6281.35 52.40 (0.84%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×